by Rasika Raman
Trends in India and genetic background
India ranks high in the list of developing countries with the greatest number of people affected with diabetes. Estimates from the World Diabetes Atlas and the WHO records place India in the top ten countries in the world with the highest burden of type 2 diabetes mellitus.
- Projected numbers for diabetes in the Indian population - 87 million by the year 2030;
- Highest prevalence found in the urban regions, compared with semi-urban and rural areas;
- Asian Indian phenotype associated with greater risk and earlier onset for type 2 diabetes (a decade earlier than Europeans) - clinical features include increased visceral fat and serum triglycerides, low HDL-levels.
Why genetic screening is useful
Type 2 diabetes is caused by impaired insulin secretion by the beta islet cells of the pancreas. Insulin is a very important hormone for metabolic function and is a key component of glucose "homeostasis" (state of balance). While investigating the mechanisms behind type 2 diabetes development and physiology, scientists have discovered at least 20 important loci (gene locations) linked to insulin function/insulin sensitivity.
Single base variations in the sequence of these genes, called Single Nucleotide Polymorphisms (SNPs, pronounced "snips") increase an individual's risk for developing type 2 diabetes. Screening for all known variations is an uphill task and reduces accuracy. However, large-scale population studies in Indians and Caucasians have successfully elucidated reliable results to help narrow down causal variants which will provide accurate risk scores, while predicting.
Scientific findings from type 2 diabetes-based studies have shown to be consistent across different races and ethnicities, for the genes mentioned above. A screening procedure that analyzes variations in these loci is useful to identify high-risk individuals, to facilitate early intervention and/or delay onset.